Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc. is a biopharmaceutical company specializing in neuroscience therapies. The company's primary focus is on developing innovative treatments for neurological and endocrine-related disorders, offering essential therapies to address unmet medical needs. Neurocrine Biosciences has significantly impacted various healthcare sectors, particularly in areas like psychiatry and endocrinology, with a product portfolio that includes drugs for conditions such as Parkinson’s disease, tardive dyskinesia, and endometriosis. Operating in a competitive and fast-paced industry, Neurocrine Biosciences collaborates with other pharmaceutical companies to leverage scientific advancements and expand its therapeutic repertoire. Founded in 1992 and headquartered in San Diego, California, the company is committed to advancing medical science through continuous research and development. Neurocrine Biosciences' contributions to the biopharmaceutical industry underscore its role in enhancing the quality of life for patients globally, solidifying its position as a key player in the market dedicated to pioneering breakthrough treatments.